Session 90: Meeting the Full Potential of DAA Therapies for HCV
The IDWeek 2019 Digital Library is intended as a resource to view IDWeek sessions virtually and claim CME credit. If you plan to claim CME credit for a session, please ensure you have first watched the session video in the DIGITAL LIBRARY prior to completing the evaluation form.
Faculty and Disclosures
David Wyles, MD; Chief Division of Infectious Diseases; Denver Health, COI Disclosures: Gilead Sciences: Grant/Research Support
Susanna Naggie, MD; Associate Professor, Duke University, COI Disclosures: "Abbvie: Grant/Research Support, BioMarin: Consultant, FHI360: Consultant, Gilead Sciences: Grant/Research Support, PRA: Consultant, Tacere: Grant/Research Support, Vir Biotechnology: Consultant"
Anne Boerekamps, MD; Resident internal medicine, Erasmus Medical Center, COI Disclosures: Nothing to disclose
Catherine Chappell, MD, MSc; Assistant Professor, University of Pittsburgh, COI Disclosures: "Gilead Sciences: Advisory Board, Research Grant, Merck: Research Grant"
Raymond Chung, MD; Director of Hepatology and Liver Center, Massachusetts General Hospital, COI Disclosures: "Abbvie: Grant/Research Support, Boeringher-Ingelheim: Grant/Research Support bristol myers squibb: Grant/Research Support, Gilead Sciences: Grant/Research Support, Janssen: Grant/Research Support, Merck: Grant/Research Support"
IDSA is accredited by the Accreditation Council for Continuing Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
IDSA designates this enduring material for a maximum of 25.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.25 AMA PRA Category 1 Credit(s)™